Statistics for ESGAR consensus statement on liver MR imaging and clinical use of liver-specific contrast agents
Total visits
| views | |
|---|---|
| ESGAR consensus statement on liver MR imaging and clinical use of liver-specific contrast agents | 102 |
Total visits per month
| views | |
|---|---|
| December 2024 | 1 |
| January 2025 | 0 |
| February 2025 | 0 |
| March 2025 | 0 |
| April 2025 | 0 |
| May 2025 | 0 |
| June 2025 | 0 |
File Visits
| views | |
|---|---|
| ESGAR Consensus.pdf(legacy) | 91 |
| ESGAR Consensus.pdf | 4 |
Top country views
| views | |
|---|---|
| China | 37 |
| United States | 31 |
| Japan | 8 |
| Canada | 7 |
| United Kingdom | 3 |
| Portugal | 3 |
| Russia | 3 |
| Germany | 2 |
| Argentina | 1 |
| Australia | 1 |
| Bulgaria | 1 |
| Brazil | 1 |
| Chile | 1 |
| Ireland | 1 |
| Italy | 1 |
| Ukraine | 1 |